Soft Tissue Tenderness and Fibromyalgia Among Schizophrenia Patients.
NCT ID: NCT05328518
Last Updated: 2022-04-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
286 participants
OBSERVATIONAL
2021-06-10
2024-09-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The association between schizophrenia and fibromyalgia is still unknown.
Study hypothesis Schizophrenia patients, who have an aberrant sensation of pain, have lower prevalence of FM compared to the general population.
Primary objectives
1. Demonstrate that schizophrenia patients have lower prevalence of FM, compared to the general population.
2. To compare the self-reported extent and intensity of pain with selected tender points examination.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Computerized Cognitive Testing in Patients Suffering From Fibromyalgia
NCT01959893
Investigation of the Relationship Between Sensory Processing and Kinesychophobia in Fibromyalgia Patients
NCT03746379
Cognitive Dysfunction in Fibromyalgia Patients
NCT01655537
Fibromyalgia in Men Suffering From PTSD
NCT00229294
Prevalence of Fibromyalgia in Israel
NCT01203865
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients must meet DSM-5 criteria for a diagnosis of schizophrenia.
* A stabled mental state.
* If hospitalized, patients are scheduled for discharge on the basis of clinical assessment of psychiatric symptoms.
Exclusion Criteria
* Diagnosis of myofascial pain syndrome or chronic fatigue syndrome.
* Alcohol or drug use.
* Usage of any pain reliever medications during the week before recruitment.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
HaEmek Medical Center, Israel
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Einat Mader
pricipal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Haemek medical center
Afula, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0052-20 EMC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.